Winsantor
PrivateLast Round
SAFE
Apr 29, 2024
Est. Valuation
$25M
Total Funding Raised
$3.69M
Momentum Score
75 /100
Company Overview
Winsantor is a private, clinical-stage biotechnology company focused on developing treatments for peripheral neuropathies, including those caused by diabetes, chemotherapy, and HIV. The company's lead product, WST-057, is a topical drug designed to regenerate peripheral nerves and has completed Phase 2 clinical trials, with Phase 3 trials being planned. Founded in 2011, Winsantor is based on research from the University of Manitoba, the University of California at San Diego, and the University of Toronto. The company has received significant funding from organizations such as the National Institutes of Health (NIH) and the Juvenile Diabetes Research Foundation to advance its research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Winsantor Comps
Public and private peers based on sector, stage, and business model.
Winsantor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Apr 29, 2024 | ||||
| Convertible Debt | Apr 28, 2020 | ||||
| Grant | May 1, 2019 | ||||
| VC Round | Nov 16, 2017 |
Key People
Founding team and executive leadership
Winsantor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Thynk Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors increased 48% MoM.
Winsantor Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Winsantor's valuation, stock price, and market status.
